• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺嗜酸细胞癌中微小RNA-221-3p、-146a-5p、-16-5p和BCL2表达的评估:病例报告

Assessment of the expression of microRNAs‑221‑3p, ‑146a‑5p, ‑16‑5p and BCL2 in oncocytic carcinoma of the breast: A case report.

作者信息

Koi Yumiko, Yamamoto Yuki, Fukunaga Saori, Kajitani Keiko, Ohara Masahiro, Daimaru Yutaka, Tahara Hidetoshi, Tamada Ryuichiro

机构信息

Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka 811-1395, Japan.

Department of Breast Surgery, Japan Agricultural Co-operatives Hiroshima General Hospital, Hatsukaichi, Hiroshima 738-8503, Japan.

出版信息

Oncol Lett. 2023 Oct 31;26(6):535. doi: 10.3892/ol.2023.14123. eCollection 2023 Dec.

DOI:10.3892/ol.2023.14123
PMID:38020289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10655050/
Abstract

Oncocytic carcinoma of the breast is rare and its molecular profiles remain poorly understood. MicroRNAs (miRNAs/miRs) have been identified as contributors to carcinogenesis at the post-transcriptional level; thus, an aberrant expression of miRNAs has attracted attention as a potential biomarker of numerous diseases, including cancer. The present study reports the case of a 76-year-old woman diagnosed with oncocytic carcinoma of the breast. Considering the distinctive feature of oncocytic carcinoma of the breast, which is the presence of granular eosinophilic cytoplasm containing numerous mitochondria, the present study hypothesized that the expression of mitochondria-related miRNAs could be altered in oncocytic carcinomas. Aberrant expression levels of the miRNAs previously reported as mitochondria-related miRNAs, such as miR-221-3p, -146a-5p and -16-5p, were revealed in tissue from specimens of oncocytic carcinoma of the breast, compared with that of a more typical type of invasive ductal carcinoma of the breast. The present study highlights the changes in miRNA expression in oncocytic carcinoma of the breast, suggesting its potential as a biomarker for diagnosis.

摘要

乳腺嗜酸细胞癌较为罕见,其分子特征仍知之甚少。微小RNA(miRNA/miR)已被确定为转录后水平致癌作用的促成因素;因此,miRNA的异常表达作为包括癌症在内的多种疾病的潜在生物标志物已受到关注。本研究报告了一例76岁女性被诊断为乳腺嗜酸细胞癌的病例。考虑到乳腺嗜酸细胞癌的独特特征,即存在含有大量线粒体的颗粒状嗜酸性细胞质,本研究推测与线粒体相关的miRNA的表达在嗜酸细胞癌中可能会发生改变。与更典型的乳腺浸润性导管癌相比,在乳腺嗜酸细胞癌标本的组织中发现了先前报道的与线粒体相关的miRNA(如miR-221-3p、-146a-5p和-16-5p)的异常表达水平。本研究强调了乳腺嗜酸细胞癌中miRNA表达的变化,表明其作为诊断生物标志物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b272/10655050/3c03675a08d7/ol-26-06-14123-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b272/10655050/5ad3a1149127/ol-26-06-14123-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b272/10655050/7dc8298509a6/ol-26-06-14123-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b272/10655050/3c03675a08d7/ol-26-06-14123-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b272/10655050/5ad3a1149127/ol-26-06-14123-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b272/10655050/7dc8298509a6/ol-26-06-14123-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b272/10655050/3c03675a08d7/ol-26-06-14123-g02.jpg

相似文献

1
Assessment of the expression of microRNAs‑221‑3p, ‑146a‑5p, ‑16‑5p and BCL2 in oncocytic carcinoma of the breast: A case report.乳腺嗜酸细胞癌中微小RNA-221-3p、-146a-5p、-16-5p和BCL2表达的评估:病例报告
Oncol Lett. 2023 Oct 31;26(6):535. doi: 10.3892/ol.2023.14123. eCollection 2023 Dec.
2
Synchronous and bilateral oncocytic carcinoma of the breast: A case report and review of the literature.乳腺同步双侧嗜酸细胞癌:一例报告并文献复习
Oncol Lett. 2017 Mar;13(3):1714-1718. doi: 10.3892/ol.2017.5610. Epub 2017 Jan 18.
3
MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.miRNA 表达谱阵列鉴定出传统和嗜酸细胞滤泡状甲状腺癌的新型诊断标志物。
J Clin Endocrinol Metab. 2013 Jan;98(1):E1-7. doi: 10.1210/jc.2012-2694. Epub 2012 Nov 12.
4
Oncocytic carcinoma of the breast: frequency, morphology and follow-up.乳腺嗜酸细胞瘤:频率、形态和随访。
Hum Pathol. 2011 Feb;42(2):166-75. doi: 10.1016/j.humpath.2010.07.014. Epub 2010 Nov 26.
5
Breast invasive ductal carcinoma diagnosis with a three-miRNA panel in serum.血清中三miRNA 标志物 panel 用于诊断乳腺浸润性导管癌。
Biomark Med. 2021 Aug;15(12):951-963. doi: 10.2217/bmm-2020-0785. Epub 2021 Jul 23.
6
MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.低分化甲状腺癌的 microRNA 谱:新的诊断和预后见解。
J Mol Endocrinol. 2014 Mar 6;52(2):181-9. doi: 10.1530/JME-13-0266. Print 2014 Apr.
7
Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.在乳腺癌中,五个 microRNA 标志物的异常表达可作为有前途的诊断生物标志物。
J Clin Lab Anal. 2020 Feb;34(2):e23063. doi: 10.1002/jcla.23063. Epub 2019 Oct 8.
8
Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.丙型肝炎病毒诱导肝细胞中微小RNA miR-146a-5p上调,促进病毒感染并失调与肝病发病机制相关的代谢途径。
J Virol. 2016 Jun 24;90(14):6387-6400. doi: 10.1128/JVI.00619-16. Print 2016 Jul 15.
9
Oncocytic carcinoma of the parotid gland. A case report.腮腺嗜酸细胞癌。病例报告。
Acta Cytol. 2003 Nov-Dec;47(6):1099-102. doi: 10.1159/000326656.
10
microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.单激素受体阳性乳腺癌中的微小RNA表达谱主要取决于HER2状态——一项初步研究
Diagnostics (Basel). 2020 Aug 20;10(9):617. doi: 10.3390/diagnostics10090617.

引用本文的文献

1
An enzyme-free electrochemical biosensor for sensitive and specific detection of microRNA-21 based on target recycling amplification and non-linear hybridization chain reaction.一种基于靶标循环扩增和非线性杂交链式反应的用于灵敏且特异性检测微小RNA-21的无酶电化学生物传感器。
Sci Rep. 2025 Jul 1;15(1):22272. doi: 10.1038/s41598-025-06003-y.

本文引用的文献

1
Type 2 Diabetes Mellitus and its comorbidity, Alzheimer's disease: Identifying critical microRNA using machine learning.2 型糖尿病及其合并症、阿尔茨海默病:使用机器学习识别关键 microRNA。
Front Endocrinol (Lausanne). 2023 Jan 19;13:1084656. doi: 10.3389/fendo.2022.1084656. eCollection 2022.
2
MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS.miRNA 146a 与 EURODIAB PCS 中 1 型糖尿病患者的糖尿病并发症相关。
J Transl Med. 2021 Nov 25;19(1):475. doi: 10.1186/s12967-021-03142-4.
3
Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period.
1 型糖尿病哺乳期母亲的富含血浆外泌体的细胞外囊泡在产后期间含有异常水平的 miRNAs。
Front Immunol. 2021 Oct 8;12:744509. doi: 10.3389/fimmu.2021.744509. eCollection 2021.
4
Cytological and molecular diagnosis of Hürthle cell thyroid tumors: Analysis of three cases.许特莱细胞甲状腺肿瘤的细胞学和分子诊断:三例分析
Mol Clin Oncol. 2021 Jul;15(1):149. doi: 10.3892/mco.2021.2311. Epub 2021 May 28.
5
The 2019 World Health Organization classification of tumours of the breast.《2019年世界卫生组织乳腺肿瘤分类》
Histopathology. 2020 Aug;77(2):181-185. doi: 10.1111/his.14091. Epub 2020 Jul 29.
6
The mitomiR/Bcl-2 axis affects mitochondrial function and autophagic vacuole formation in senescent endothelial cells.线粒体微小RNA/ Bcl-2轴影响衰老内皮细胞的线粒体功能和自噬空泡形成。
Aging (Albany NY). 2018 Oct 21;10(10):2855-2873. doi: 10.18632/aging.101591.
7
The Influence of MicroRNAs on Mitochondrial Calcium.微小RNA对线粒体钙的影响。
Front Physiol. 2018 Sep 21;9:1291. doi: 10.3389/fphys.2018.01291. eCollection 2018.
8
Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5.miR-146a-5p通过调控SOX5对三阴性乳腺癌增殖和转移的影响
Exp Ther Med. 2018 May;15(5):4515-4521. doi: 10.3892/etm.2018.5945. Epub 2018 Mar 9.
9
Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells?线粒体(功能)障碍与衰老相关炎症:微小核糖核酸(miRNAs)是否影响衰老细胞的能量代谢、氧化应激和炎症状态?
Mediators Inflamm. 2017;2017:2309034. doi: 10.1155/2017/2309034. Epub 2017 Dec 27.
10
A miRNA-based classification of renal cell carcinoma subtypes by PCR and hybridization.通过聚合酶链式反应(PCR)和杂交技术对肾细胞癌亚型进行基于微小RNA(miRNA)的分类。
Oncotarget. 2017 Dec 8;9(2):2092-2104. doi: 10.18632/oncotarget.23162. eCollection 2018 Jan 5.